Substance Abuse
News Category

American Heart Association Study Seeks Real-World Weight Journeys to Improve Care
A new American Heart Association study aims to understand the diverse factors shaping weight and health outcomes by learning directly from U.S. adults...

Oral GLP-1 Pill Cuts Sleep Apnea Breathing Interruptions by 18 Events per Hour in Year-Long Trials
New late-breaking research presented at the American Heart Association's Scientific Sessions 2026 shows the daily oral GLP-1 medication orforglipron s...

Wolfson Group Expands PhenQ Distribution as GLP-1 Use Surges Among U.S. Households
Wolfson Group is broadening U.S. access to its non-prescription PhenQ weight management brand while emphasizing consumer education as GLP-1 medication...

Podcaster Suzy Chase Shifts Focus from Cookbooks to GLP-1 Maintenance
Suzy Chase, a podcasting pioneer with 8 million lifetime downloads, is now hosting Dinner Party on a GLP-1, a show about life after weight loss on GLP...

Wolfson Group Expands U.S. Weight Management Portfolio with PhenQ on OneLavi
Wolfson Group has added PhenQ to OneLavi.com, giving U.S. consumers a new online retail destination for the weight management brand as part of a broad...

Weight Loss Medications Bring 'Ozempic Face' into Focus as Vancouver Clinic Distinguishes Botox from Fillers
As GLP-1 weight-loss drugs like Ozempic and Wegovy gain popularity, facial volume loss—dubbed 'Ozempic face'—is driving interest in non-surgical rejuv...

OMRON Healthcare Launches VIVA 360+ Full-Body Smart Scale in the U.S., Offering Up to 18 Metrics and Athlete Mode
OMRON Healthcare has launched the VIVA 360+ Full-Body Smart Scale in the U.S., a connected body composition monitor that tracks up to 18 metrics and i...

Wolfson Group Expands U.S. Reach with OneLavi Deal for Three Wellness Brands
Wolfson Group is bringing three of its wellness brands to OneLavi.com, advancing its strategy to diversify U.S. distribution beyond Amazon.

Wolfson Group Completes ECRM Meetings as Part of U.S. Retail Expansion
Wolfson Group's participation in the ECRM Vitamin, Weight Management & Sports Nutrition Session signals its push to expand beyond Amazon into U.S. bri...

Wolfson Group Targets U.S. Retail Expansion at ECRM Event
Wolfson Group will attend the ECRM Vitamin, Weight Management & Sports Nutrition Session to meet with U.S. retailers and expand its wellness brands be...

New Bilingual Telehealth Clinic Launches to Address GLP-1 Access Gap for Latino Patients
Sol y Vida Clinic, a bilingual telehealth platform, launched nationwide to tackle the stark disparity in GLP-1 medication access for Hispanic patients...

FDA Inaction Allows Black Market for Unapproved Weight-Loss Drug to Flourish Online
The FDA's failure to aggressively combat the illegal online sale of retatrutide, an unapproved investigational drug, has led to a dangerous black mark...

Companies Rethink GLP-1 Drug Coverage as Costs and Questions Mount
As GLP-1 drug use surges, many U.S. companies are discontinuing coverage in employee health plans, prompting a deeper look into the reasons and implic...

School-Based Plyo-HIIT Program Aims to Improve Muscle-to-Fat Ratio in Children
A new randomized controlled trial tests whether a school-based plyometric and high-intensity interval training program can improve muscle-to-fat ratio...

Wolfson Group Highlights Shift Toward Informed Wellness in Weight Management
Wolfson Group discusses how evolving consumer trends are reshaping the weight management market, emphasizing transparency and multi-ingredient formula...

Illicit Retatrutide Sales Surge: What Consumers Need to Know
Retatrutide, an unapproved investigational drug, is being illegally sold online, leading to a 265% increase in poison control reports and hospitalizat...

New Precision Obesity Models Aim to Close Translational Gap in Anti-Obesity Drug Development
As next-generation obesity therapies emerge, traditional preclinical models fall short, prompting Protheragen Obesity to launch a tiered system of gen...

Nashville Concierge Medicines Releases New Educational Content on GLP-1 Treatment for Diabetes
Nashville Concierge Medicines announces new content for confidential patient care, focusing on GLP-1 medications to help manage diabetes, blood sugar ...
